UCAN CURE – Precision Decisions for Childhood Arthritis
Childhood arthritis describes a group of diseases that commonly present as pain, stiffness and swelling of the joints and other supporting structures of the body.
Paediatric patients who are diagnosed with arthritis are often faced with debilitating symptoms that can dramatically decrease quality of life. This can also lead to lifelong chronic rheumatic disease.
As such, providing timely and effective interventions is crucial for improving short and long term health outcomes for children living with this disease.
~20,000
children in Canada and the Netherlands are affected by juvenile idiopathic arthritis (JIA) – the most common immune-mediated inflammatory musculoskeletal disease
Biologics
are advanced therapeutic agents often required by children who are at high-risk of permanent joint damage due to their arthritis
1 in 3
paediatric and adult patients currently receive biologic therapies for arthritis without any treatment end-date